Living

US FDA greenlights Viridian's eye disease drug

By Reuters Reuters
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly ANDREW KELLY Reuters

The U.S. Food and Drug Administration has approved Viridian Therapeutics' drug to treat patients with thyroid eye disease, the company said on Friday.

(Reporting by Siddhi Mahatole and Puyaan Singh in Bengaluru; Editing by Vijay Kishore)

Copyright Reuters or USA Today Network via Reuters Connect

This story was originally published June 26, 2026 at 6:07 PM.

Get unlimited digital access
#ReadLocal

Try 1 month for $1

CLAIM OFFER